1. Home
  2. ADPT vs THO Comparison

ADPT vs THO Comparison

Compare ADPT & THO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

N/A

Current Price

$27.73

Market Cap

4.6B

Sector

Health Care

ML Signal

N/A

Logo Thor Industries Inc.

THO

Thor Industries Inc.

N/A

Current Price

$75.22

Market Cap

4.0B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
ADPT
THO
Founded
2009
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Homebuilding
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
4.0B
IPO Year
2019
1994

Fundamental Metrics

Financial Performance
Metric
ADPT
THO
Price
$27.73
$75.22
Analyst Decision
Strong Buy
Hold
Analyst Count
8
18
Target Price
$33.86
★ $82.91
AVG Volume (30 Days)
★ 2.1M
775.7K
Earning Date
11-04-2026
12-02-2026
Dividend Yield
N/A
★ 2.84%
EPS Growth
★ 63.89
N/A
EPS
N/A
★ 3.38
Revenue
$276,976,000.00
★ $9,608,145,000.00
Revenue This Year
$10.85
$0.72
Revenue Next Year
$21.60
$4.72
P/E Ratio
★ N/A
$22.49
Revenue Growth
★ 54.77
0.30
52 Week Low
$12.00
$62.83
52 Week High
$32.21
$122.83

Technical Indicators

Market Signals
Indicator
ADPT
THO
Relative Strength Index (RSI) 49.06 49.02
Support Level $24.02 $74.74
Resistance Level $29.92 $81.37
Average True Range (ATR) 1.71 3.00
MACD -0.09 -0.62
Stochastic Oscillator 31.91 2.15

Price Performance

Historical Comparison
ADPT
THO

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.

About THO Thor Industries Inc.

Based in Elkhart, Indiana, Thor Industries manufactures Class A, Class B, and Class C motor homes along with travel trailers and fifth-wheel towables across over 30 brands. Through the acquisition of Erwin Hymer in 2019, the company expanded its geographic footprint and now produces various motorized and towable recreational vehicles for Europe, including motor caravans, camper vans, urban vehicles, caravans, and other RV-related products and services. The company has also begun generating revenue through aftermarket component parts via the acquisition of Airxcel in 2021, which is about 10% of sales. In fiscal 2026, the company wholesaled 159,956 units and generated $9.6 billion in revenue.

Share on Social Networks: